This paper reviews how mesenchymal stem cell-derived exosomes are being explored as a new remedy for neurocognitive disorders — conditions affecting memory, thinking, and behavior. By targeting inflammation and supporting neural health, exosomes may slow or reverse certain cognitive symptoms.

For patients and families affected by cognitive decline, this is an important emerging area of research.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.